Pentoxifylline Tablet, Extended Release
Product Images NDC 16571-856

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 16571-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pentoxifyllinelabel (Pentoxifyllinelabel)

This text provides details about Pentoxifylline Extended-Release Tablets, USP, with a strength of 400 mg and a quantity of 500 tablets. The usual dosage recommends one tablet three times a day with meals. It advises storing the medication in a tight light-resistant container, at a temperature between 20° to 25°C, protected from light. The manufacturer is Rising Pharma Holdings, Inc, and the product is made in India. Additionally, it includes a code number, issuance date, and a reference number LR85650-00 for tracking purposes.*

FDA Label Image

Pentoxifyllinestruct (Pentoxifyllinestruct)

FDA Label Image

Pentoxifyllinetable (Pentoxifyllinetable)

This text provides a detailed breakdown of the side effects experienced by patients participating in clinical trials involving the use of extended-release tablets and immediate-release capsules of Pentoxifylline and Placebo. The data categorizes the side effects by body system, such as cardiovascular, digestive, and nervous systems, listing symptoms like chest pain, palpitations, abdominal discomfort, bloating, dizziness, headache, insomnia, and blurred vision among others. This information is valuable for healthcare professionals and researchers evaluating the safety and tolerability of these medications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.